Gait Analysis in MPS IVA

Interested in this Trial?

Contact Us

Trial Status Completed

Trial Identifier

NCT01920828

Condition

MPS IVA, Morquio Syndrome

The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc. and has not been edited.

Trial Summary

The purpose of this study is to learn about gait (walking) characteristics in MPS IVA and possible changes in gait with enzyme replacement therapy.

Eligibility Criteria

Birth Sex

All

Age

From 1 Year

Healthy Volunteers

No

Study Type:

Observational

Number of Participants:

10

Study Started:

2013-08

Study Updated:

2019-10-17

Trial Locations

  • Oregon Health and Science University

    Portland, Oregon, United States

Inclusion Criteria

-Diagnosis of MPS IVA

Exclusion Criteria

Non-ambulatory

  • Previous enrolled in clinical trial BMN-11

Contact BioMarin Clinical Trials

Please complete and submit the following form to express interest in participating and request more information about one of our clinical trials.

By completing this form and clicking the send button, you understand and hereby consent to storage of your personal information, including within the United States and Europe, which will be accessible by BioMarin for purposes such as responding to your request, quality control, fulfilling compliance obligations, and assisting with products, services, or clinical trials. Depending on where you live, you may have the right to request access to, removal, or correction of your personal information held by BioMarin. You may submit your request via the contact information and/or webform located within the full BioMarin Privacy Policy.

*required fields

"*" indicates required fields

This field is hidden when viewing the form
This field is hidden when viewing the form